0

Development of Novel NK3 Receptor Antagonists With Reduced Environmental Impact

Koki Yamamoto, Shiho Okazaki, Hiroaki Ohno, Fuko Matsuda, Satoshi Ohkura, Kei-Ichiro Maeda, Nobutaka Fujii, Shinya Oishi

Bioorg Med Chem. 2016 Aug 15;24(16):3494-500.

PMID: 27298001

Abstract:

The neurokinin B (NKB)-neurokinin-3 receptor (NK3R) signaling positively regulates the release of gonadotropin-releasing hormone (GnRH) from the hypothalamus. The NK3R-selective antagonists may suppress the reproductive functions of mammals. For development of novel NK3R antagonists with reduced environmental toxicity, a structure-activity relationship study of an NK3R antagonist, talnetant, was carried out. Among several talnetant derivatives with labile functional groups in the natural environment, 3-mercaptoquinoline 2f exhibited a comparable biological activity to that of the parent talnetant. Additionally, compound 2f was converted into the disulfide 3f or isothiazolone 8 by air-oxidation, both of which showed no binding affinity to NK3R.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP174636329 Talnetant Talnetant 174636-32-9 Price
qrcode